← Back
Data updated: Mar 10, 2026
PVT FORM
GastroenterologyCardiovascularInfectious Disease
PVT FORM is a pharmaceutical company focused on Gastroenterology, Cardiovascular, Infectious Disease.
1975
Since
25
Drugs
-
Trials
228
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
DOXYCYCLINE HYCLATE 2026-02-19
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
CHLORPROMAZINE HYDROCHLORIDE 2026-01-26
DOXYCYCLINE HYCLATE 2026-01-26
Labeling
DOXYCYCLINE HYCLATE 2026-01-20
Labeling
DOXYCYCLINE HYCLATE 2026-01-20
Labeling
DOXYCYCLINE HYCLATE 2026-01-18
Labeling
DOXYCYCLINE HYCLATE 2025-12-09
DOXYCYCLINE HYCLATE 2025-11-19
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Gastroenterology 33%
2 drugs
Cardiovascular 17%
1 drugs
Infectious Disease 17%
1 drugs
Respiratory 17%
1 drugs
Dermatology 17%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
APOTHECON specialty
Infectious Disease, Dermatology, Cardiovascular, Gastroenterology, Respiratory
Pfizer big-pharma
Infectious Disease, Dermatology, Gastroenterology
Baxter specialty
Infectious Disease, Cardiovascular, Dermatology
LEDERLE big-pharma
Infectious Disease, Cardiovascular, Dermatology, Respiratory
B BRAUN specialty
Infectious Disease, Dermatology, Cardiovascular
Discontinued (21)
CHLORPROMAZINE HYDROCHLORIDE DIPHENHYDRAMINE HYDROCHLORIDE PREDNISONE DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE METHYLTESTOSTERONE PROMETHAZINE HYDROCHLORIDE PREDNISOLONE TETRACYCLINE HYDROCHLORIDE PHENDIMETRAZINE TARTRATE RESERPINE MEPROBAMATE PROPOXYPHENE HYDROCHLORIDE CHLORPHENIRAMINE MALEATE PROPANTHELINE BROMIDE BROMPHENIRAMINE MALEATE ALLERFED FEMOGEN DI-METREX BENZTHIAZIDE RAUWOLFIA SERPENTINA ESTERIFIED ESTROGENS
Company Info
- First Approval
- 1975-02-21
- Latest
- 1986-07-24
- Applications
- 36